1.
PLoS Negl Trop Dis
; 14(9): e0007956, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32881862
RESUMO
In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new venture is known as the Research Investment for Global Health Technology (RIGHT) Fund.
